nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—Myasthenia—Carmustine—malignant glioma	0.0138	0.0193	CcSEcCtD
Indapamide—Oral candidiasis—Carmustine—malignant glioma	0.0137	0.0191	CcSEcCtD
Indapamide—Oral candidiasis—Temozolomide—malignant glioma	0.0132	0.0184	CcSEcCtD
Indapamide—Tooth disorder—Temozolomide—malignant glioma	0.0129	0.018	CcSEcCtD
Indapamide—Digestion impaired—Temozolomide—malignant glioma	0.0126	0.0175	CcSEcCtD
Indapamide—Myopathy—Temozolomide—malignant glioma	0.012	0.0167	CcSEcCtD
Indapamide—Lung disorder—Temozolomide—malignant glioma	0.0119	0.0165	CcSEcCtD
Indapamide—Hyperaesthesia—Temozolomide—malignant glioma	0.0107	0.0149	CcSEcCtD
Indapamide—Drug interaction—Carmustine—malignant glioma	0.00937	0.0131	CcSEcCtD
Indapamide—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00888	0.0124	CcSEcCtD
Indapamide—Vaginal inflammation—Temozolomide—malignant glioma	0.0084	0.0117	CcSEcCtD
Indapamide—Candida infection—Carmustine—malignant glioma	0.0083	0.0116	CcSEcCtD
Indapamide—Candida infection—Temozolomide—malignant glioma	0.00802	0.0112	CcSEcCtD
Indapamide—Vaginal infection—Temozolomide—malignant glioma	0.00793	0.011	CcSEcCtD
Indapamide—Aplastic anaemia—Temozolomide—malignant glioma	0.00789	0.011	CcSEcCtD
Indapamide—Diabetes mellitus—Carmustine—malignant glioma	0.00725	0.0101	CcSEcCtD
Indapamide—Ear pain—Temozolomide—malignant glioma	0.00715	0.00995	CcSEcCtD
Indapamide—Gastroenteritis—Temozolomide—malignant glioma	0.00688	0.00958	CcSEcCtD
Indapamide—Vascular purpura—Temozolomide—malignant glioma	0.00682	0.00949	CcSEcCtD
Indapamide—Hepatic failure—Temozolomide—malignant glioma	0.00678	0.00945	CcSEcCtD
Indapamide—Amnesia—Carmustine—malignant glioma	0.00671	0.00935	CcSEcCtD
Indapamide—Amnesia—Temozolomide—malignant glioma	0.00649	0.00904	CcSEcCtD
Indapamide—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00646	0.009	CcSEcCtD
Indapamide—Hyponatraemia—Carmustine—malignant glioma	0.00633	0.00882	CcSEcCtD
Indapamide—Purpura—Temozolomide—malignant glioma	0.00633	0.00881	CcSEcCtD
Indapamide—Face oedema—Carmustine—malignant glioma	0.00609	0.00848	CcSEcCtD
Indapamide—Ataxia—Carmustine—malignant glioma	0.00593	0.00826	CcSEcCtD
Indapamide—Face oedema—Temozolomide—malignant glioma	0.00589	0.0082	CcSEcCtD
Indapamide—Liver function test abnormal—Carmustine—malignant glioma	0.00582	0.00811	CcSEcCtD
Indapamide—Hypokalaemia—Carmustine—malignant glioma	0.00574	0.008	CcSEcCtD
Indapamide—Ataxia—Temozolomide—malignant glioma	0.00573	0.00799	CcSEcCtD
Indapamide—Dehydration—Temozolomide—malignant glioma	0.00567	0.0079	CcSEcCtD
Indapamide—Muscular weakness—Carmustine—malignant glioma	0.00556	0.00775	CcSEcCtD
Indapamide—Hypokalaemia—Temozolomide—malignant glioma	0.00555	0.00773	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00549	0.00765	CcSEcCtD
Indapamide—Dysphagia—Carmustine—malignant glioma	0.00545	0.0076	CcSEcCtD
Indapamide—Muscular weakness—Temozolomide—malignant glioma	0.00538	0.00749	CcSEcCtD
Indapamide—Dysphagia—Temozolomide—malignant glioma	0.00527	0.00734	CcSEcCtD
Indapamide—Bronchitis—Temozolomide—malignant glioma	0.00507	0.00706	CcSEcCtD
Indapamide—Dysuria—Temozolomide—malignant glioma	0.00493	0.00686	CcSEcCtD
Indapamide—Hyperglycaemia—Carmustine—malignant glioma	0.00492	0.00685	CcSEcCtD
Indapamide—Pneumonia—Carmustine—malignant glioma	0.00489	0.00681	CcSEcCtD
Indapamide—Pollakiuria—Temozolomide—malignant glioma	0.00487	0.00678	CcSEcCtD
Indapamide—Erectile dysfunction—Temozolomide—malignant glioma	0.00485	0.00676	CcSEcCtD
Indapamide—Depression—Carmustine—malignant glioma	0.00485	0.00675	CcSEcCtD
Indapamide—Photosensitivity reaction—Temozolomide—malignant glioma	0.00481	0.0067	CcSEcCtD
Indapamide—Renal failure—Carmustine—malignant glioma	0.00478	0.00666	CcSEcCtD
Indapamide—Weight decreased—Temozolomide—malignant glioma	0.00477	0.00664	CcSEcCtD
Indapamide—Hyperglycaemia—Temozolomide—malignant glioma	0.00475	0.00662	CcSEcCtD
Indapamide—Stomatitis—Carmustine—malignant glioma	0.00474	0.0066	CcSEcCtD
Indapamide—Urinary tract infection—Carmustine—malignant glioma	0.00473	0.00658	CcSEcCtD
Indapamide—Pneumonia—Temozolomide—malignant glioma	0.00473	0.00658	CcSEcCtD
Indapamide—Depression—Temozolomide—malignant glioma	0.00468	0.00653	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00466	0.00649	CcSEcCtD
Indapamide—Stomatitis—Temozolomide—malignant glioma	0.00458	0.00638	CcSEcCtD
Indapamide—Urinary tract infection—Temozolomide—malignant glioma	0.00457	0.00636	CcSEcCtD
Indapamide—Hepatobiliary disease—Temozolomide—malignant glioma	0.00444	0.00619	CcSEcCtD
Indapamide—Sinusitis—Temozolomide—malignant glioma	0.00441	0.00614	CcSEcCtD
Indapamide—Hypoaesthesia—Carmustine—malignant glioma	0.00434	0.00605	CcSEcCtD
Indapamide—Oedema peripheral—Carmustine—malignant glioma	0.0043	0.00599	CcSEcCtD
Indapamide—Hepatitis—Temozolomide—malignant glioma	0.00422	0.00588	CcSEcCtD
Indapamide—Visual impairment—Carmustine—malignant glioma	0.00421	0.00586	CcSEcCtD
Indapamide—Hypoaesthesia—Temozolomide—malignant glioma	0.0042	0.00585	CcSEcCtD
Indapamide—Pharyngitis—Temozolomide—malignant glioma	0.00419	0.00583	CcSEcCtD
Indapamide—Urinary tract disorder—Temozolomide—malignant glioma	0.00417	0.0058	CcSEcCtD
Indapamide—Oedema peripheral—Temozolomide—malignant glioma	0.00415	0.00579	CcSEcCtD
Indapamide—Urethral disorder—Temozolomide—malignant glioma	0.00413	0.00576	CcSEcCtD
Indapamide—Visual impairment—Temozolomide—malignant glioma	0.00406	0.00566	CcSEcCtD
Indapamide—Flushing—Carmustine—malignant glioma	0.00405	0.00564	CcSEcCtD
Indapamide—Erythema multiforme—Temozolomide—malignant glioma	0.00399	0.00555	CcSEcCtD
Indapamide—Tinnitus—Temozolomide—malignant glioma	0.00393	0.00548	CcSEcCtD
Indapamide—Cardiac disorder—Temozolomide—malignant glioma	0.00391	0.00545	CcSEcCtD
Indapamide—Flushing—Temozolomide—malignant glioma	0.00391	0.00545	CcSEcCtD
Indapamide—Arrhythmia—Carmustine—malignant glioma	0.0039	0.00543	CcSEcCtD
Indapamide—Erythema—Carmustine—malignant glioma	0.0038	0.00529	CcSEcCtD
Indapamide—Malnutrition—Carmustine—malignant glioma	0.0038	0.00529	CcSEcCtD
Indapamide—Back pain—Carmustine—malignant glioma	0.00368	0.00512	CcSEcCtD
Indapamide—Malnutrition—Temozolomide—malignant glioma	0.00367	0.00511	CcSEcCtD
Indapamide—Erythema—Temozolomide—malignant glioma	0.00367	0.00511	CcSEcCtD
Indapamide—Dysgeusia—Temozolomide—malignant glioma	0.0036	0.00501	CcSEcCtD
Indapamide—Vision blurred—Carmustine—malignant glioma	0.00358	0.00499	CcSEcCtD
Indapamide—Back pain—Temozolomide—malignant glioma	0.00355	0.00495	CcSEcCtD
Indapamide—Anaemia—Carmustine—malignant glioma	0.00351	0.00489	CcSEcCtD
Indapamide—Agitation—Carmustine—malignant glioma	0.00349	0.00486	CcSEcCtD
Indapamide—Vision blurred—Temozolomide—malignant glioma	0.00346	0.00482	CcSEcCtD
Indapamide—Ill-defined disorder—Temozolomide—malignant glioma	0.00341	0.00475	CcSEcCtD
Indapamide—Leukopenia—Carmustine—malignant glioma	0.0034	0.00474	CcSEcCtD
Indapamide—Anaemia—Temozolomide—malignant glioma	0.00339	0.00473	CcSEcCtD
Indapamide—Agitation—Temozolomide—malignant glioma	0.00337	0.0047	CcSEcCtD
Indapamide—Angioedema—Temozolomide—malignant glioma	0.00335	0.00467	CcSEcCtD
Indapamide—Malaise—Temozolomide—malignant glioma	0.00331	0.00461	CcSEcCtD
Indapamide—Vertigo—Temozolomide—malignant glioma	0.0033	0.00459	CcSEcCtD
Indapamide—Leukopenia—Temozolomide—malignant glioma	0.00329	0.00458	CcSEcCtD
Indapamide—Palpitations—Temozolomide—malignant glioma	0.00324	0.00452	CcSEcCtD
Indapamide—Chest pain—Carmustine—malignant glioma	0.00323	0.00451	CcSEcCtD
Indapamide—Myalgia—Carmustine—malignant glioma	0.00323	0.00451	CcSEcCtD
Indapamide—Anxiety—Carmustine—malignant glioma	0.00322	0.00449	CcSEcCtD
Indapamide—Cough—Temozolomide—malignant glioma	0.0032	0.00446	CcSEcCtD
Indapamide—Myalgia—Temozolomide—malignant glioma	0.00313	0.00435	CcSEcCtD
Indapamide—Arthralgia—Temozolomide—malignant glioma	0.00313	0.00435	CcSEcCtD
Indapamide—Anxiety—Temozolomide—malignant glioma	0.00312	0.00434	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0031	0.00432	CcSEcCtD
Indapamide—Oedema—Carmustine—malignant glioma	0.0031	0.00432	CcSEcCtD
Indapamide—Discomfort—Temozolomide—malignant glioma	0.00309	0.0043	CcSEcCtD
Indapamide—Infection—Carmustine—malignant glioma	0.00308	0.00429	CcSEcCtD
Indapamide—Dry mouth—Temozolomide—malignant glioma	0.00306	0.00426	CcSEcCtD
Indapamide—Thrombocytopenia—Carmustine—malignant glioma	0.00304	0.00423	CcSEcCtD
Indapamide—Tachycardia—Carmustine—malignant glioma	0.00303	0.00422	CcSEcCtD
Indapamide—Oedema—Temozolomide—malignant glioma	0.003	0.00417	CcSEcCtD
Indapamide—Anaphylactic shock—Temozolomide—malignant glioma	0.003	0.00417	CcSEcCtD
Indapamide—Infection—Temozolomide—malignant glioma	0.00298	0.00415	CcSEcCtD
Indapamide—Anorexia—Carmustine—malignant glioma	0.00296	0.00412	CcSEcCtD
Indapamide—Nervous system disorder—Temozolomide—malignant glioma	0.00294	0.00409	CcSEcCtD
Indapamide—Thrombocytopenia—Temozolomide—malignant glioma	0.00293	0.00409	CcSEcCtD
Indapamide—Skin disorder—Temozolomide—malignant glioma	0.00291	0.00405	CcSEcCtD
Indapamide—Hypotension—Carmustine—malignant glioma	0.0029	0.00404	CcSEcCtD
Indapamide—Hyperhidrosis—Temozolomide—malignant glioma	0.0029	0.00404	CcSEcCtD
Indapamide—Anorexia—Temozolomide—malignant glioma	0.00286	0.00398	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00283	0.00394	CcSEcCtD
Indapamide—Insomnia—Carmustine—malignant glioma	0.0028	0.00391	CcSEcCtD
Indapamide—Paraesthesia—Carmustine—malignant glioma	0.00278	0.00388	CcSEcCtD
Indapamide—Dyspnoea—Carmustine—malignant glioma	0.00276	0.00385	CcSEcCtD
Indapamide—Somnolence—Carmustine—malignant glioma	0.00276	0.00384	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00273	0.0038	CcSEcCtD
Indapamide—Insomnia—Temozolomide—malignant glioma	0.00271	0.00378	CcSEcCtD
Indapamide—Decreased appetite—Carmustine—malignant glioma	0.0027	0.00375	CcSEcCtD
Indapamide—Paraesthesia—Temozolomide—malignant glioma	0.00269	0.00375	CcSEcCtD
Indapamide—Gastrointestinal disorder—Carmustine—malignant glioma	0.00268	0.00373	CcSEcCtD
Indapamide—CA7—midbrain—malignant glioma	0.00267	0.0685	CbGeAlD
Indapamide—Dyspnoea—Temozolomide—malignant glioma	0.00267	0.00372	CcSEcCtD
Indapamide—KCNQ1—medulla oblongata—malignant glioma	0.00266	0.0683	CbGeAlD
Indapamide—Somnolence—Temozolomide—malignant glioma	0.00266	0.00371	CcSEcCtD
Indapamide—Pain—Carmustine—malignant glioma	0.00265	0.00369	CcSEcCtD
Indapamide—Constipation—Carmustine—malignant glioma	0.00265	0.00369	CcSEcCtD
Indapamide—Dyspepsia—Temozolomide—malignant glioma	0.00264	0.00367	CcSEcCtD
Indapamide—Decreased appetite—Temozolomide—malignant glioma	0.0026	0.00363	CcSEcCtD
Indapamide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00259	0.0036	CcSEcCtD
Indapamide—Fatigue—Temozolomide—malignant glioma	0.00258	0.0036	CcSEcCtD
Indapamide—Constipation—Temozolomide—malignant glioma	0.00256	0.00357	CcSEcCtD
Indapamide—Pain—Temozolomide—malignant glioma	0.00256	0.00357	CcSEcCtD
Indapamide—Feeling abnormal—Carmustine—malignant glioma	0.00256	0.00356	CcSEcCtD
Indapamide—Gastrointestinal pain—Carmustine—malignant glioma	0.00254	0.00353	CcSEcCtD
Indapamide—Feeling abnormal—Temozolomide—malignant glioma	0.00247	0.00344	CcSEcCtD
Indapamide—Body temperature increased—Carmustine—malignant glioma	0.00245	0.00341	CcSEcCtD
Indapamide—Abdominal pain—Carmustine—malignant glioma	0.00245	0.00341	CcSEcCtD
Indapamide—Gastrointestinal pain—Temozolomide—malignant glioma	0.00245	0.00341	CcSEcCtD
Indapamide—CA12—telencephalon—malignant glioma	0.00242	0.062	CbGeAlD
Indapamide—Urticaria—Temozolomide—malignant glioma	0.00238	0.00332	CcSEcCtD
Indapamide—Body temperature increased—Temozolomide—malignant glioma	0.00237	0.0033	CcSEcCtD
Indapamide—Abdominal pain—Temozolomide—malignant glioma	0.00237	0.0033	CcSEcCtD
Indapamide—Hypersensitivity—Carmustine—malignant glioma	0.00228	0.00318	CcSEcCtD
Indapamide—Asthenia—Carmustine—malignant glioma	0.00222	0.0031	CcSEcCtD
Indapamide—Hypersensitivity—Temozolomide—malignant glioma	0.00221	0.00308	CcSEcCtD
Indapamide—Asthenia—Temozolomide—malignant glioma	0.00215	0.00299	CcSEcCtD
Indapamide—Diarrhoea—Carmustine—malignant glioma	0.00212	0.00296	CcSEcCtD
Indapamide—Pruritus—Temozolomide—malignant glioma	0.00212	0.00295	CcSEcCtD
Indapamide—CA7—cerebellum—malignant glioma	0.00207	0.053	CbGeAlD
Indapamide—Dizziness—Carmustine—malignant glioma	0.00205	0.00286	CcSEcCtD
Indapamide—Diarrhoea—Temozolomide—malignant glioma	0.00205	0.00286	CcSEcCtD
Indapamide—Dizziness—Temozolomide—malignant glioma	0.00198	0.00276	CcSEcCtD
Indapamide—Vomiting—Carmustine—malignant glioma	0.00197	0.00275	CcSEcCtD
Indapamide—Rash—Carmustine—malignant glioma	0.00196	0.00272	CcSEcCtD
Indapamide—Dermatitis—Carmustine—malignant glioma	0.00195	0.00272	CcSEcCtD
Indapamide—Headache—Carmustine—malignant glioma	0.00194	0.00271	CcSEcCtD
Indapamide—Vomiting—Temozolomide—malignant glioma	0.00191	0.00265	CcSEcCtD
Indapamide—Rash—Temozolomide—malignant glioma	0.00189	0.00263	CcSEcCtD
Indapamide—Dermatitis—Temozolomide—malignant glioma	0.00189	0.00263	CcSEcCtD
Indapamide—Headache—Temozolomide—malignant glioma	0.00188	0.00261	CcSEcCtD
Indapamide—Nausea—Carmustine—malignant glioma	0.00184	0.00257	CcSEcCtD
Indapamide—CA9—cerebellum—malignant glioma	0.00182	0.0465	CbGeAlD
Indapamide—Nausea—Temozolomide—malignant glioma	0.00178	0.00248	CcSEcCtD
Indapamide—CA4—brainstem—malignant glioma	0.00169	0.0432	CbGeAlD
Indapamide—CA7—brain—malignant glioma	0.00168	0.043	CbGeAlD
Indapamide—KCNQ1—brain—malignant glioma	0.00153	0.0392	CbGeAlD
Indapamide—CA2—embryo—malignant glioma	0.00153	0.0391	CbGeAlD
Indapamide—CA4—telencephalon—malignant glioma	0.0015	0.0384	CbGeAlD
Indapamide—CA2—brainstem—malignant glioma	0.0014	0.0358	CbGeAlD
Indapamide—CA12—central nervous system—malignant glioma	0.00137	0.0352	CbGeAlD
Indapamide—CA2—retina—malignant glioma	0.00135	0.0346	CbGeAlD
Indapamide—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.00132	0.00542	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—APOD—malignant glioma	0.00131	0.00537	CbGpPWpGaD
Indapamide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00125	0.00516	CbGpPWpGaD
Indapamide—CA2—telencephalon—malignant glioma	0.00124	0.0318	CbGeAlD
Indapamide—CA5B—central nervous system—malignant glioma	0.00123	0.0316	CbGeAlD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00121	0.00497	CbGpPWpGaD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.0012	0.00492	CbGpPWpGaD
Indapamide—CA4—Metabolism—RTEL1—malignant glioma	0.00118	0.00486	CbGpPWpGaD
Indapamide—CA4—medulla oblongata—malignant glioma	0.00118	0.0301	CbGeAlD
Indapamide—CA9—Cellular responses to stress—HIST1H3B—malignant glioma	0.00116	0.00478	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00115	0.00473	CbGpPWpGaD
Indapamide—CA2—Metabolism—RTEL1—malignant glioma	0.00113	0.00466	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.00111	0.00457	CbGpPWpGaD
Indapamide—CA12—brain—malignant glioma	0.00109	0.028	CbGeAlD
Indapamide—CA4—midbrain—malignant glioma	0.00108	0.0276	CbGeAlD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.00106	0.00438	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.00106	0.00437	CbGpPWpGaD
Indapamide—CA4—spinal cord—malignant glioma	0.00105	0.0269	CbGeAlD
Indapamide—CA5A—Metabolism—COX8A—malignant glioma	0.000983	0.00405	CbGpPWpGaD
Indapamide—CA5B—brain—malignant glioma	0.000979	0.0251	CbGeAlD
Indapamide—CA2—medulla oblongata—malignant glioma	0.000976	0.025	CbGeAlD
Indapamide—CA9—Metabolism—RTEL1—malignant glioma	0.000954	0.00393	CbGpPWpGaD
Indapamide—CA7—Metabolism—COX8A—malignant glioma	0.000918	0.00378	CbGpPWpGaD
Indapamide—CA5B—Metabolism—COX8A—malignant glioma	0.000918	0.00378	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000902	0.00371	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—H3F3A—malignant glioma	0.000897	0.00369	CbGpPWpGaD
Indapamide—CA2—midbrain—malignant glioma	0.000892	0.0228	CbGeAlD
Indapamide—KCNQ1—Neuronal System—BRAF—malignant glioma	0.00089	0.00366	CbGpPWpGaD
Indapamide—CA2—spinal cord—malignant glioma	0.00087	0.0223	CbGeAlD
Indapamide—CA9—Cellular responses to stress—YWHAE—malignant glioma	0.000864	0.00355	CbGpPWpGaD
Indapamide—CA4—central nervous system—malignant glioma	0.000851	0.0218	CbGeAlD
Indapamide—CA12—Metabolism—COX8A—malignant glioma	0.00085	0.0035	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ASMT—malignant glioma	0.000836	0.00344	CbGpPWpGaD
Indapamide—CA4—cerebellum—malignant glioma	0.000832	0.0213	CbGeAlD
Indapamide—CA9—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000829	0.00341	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000814	0.00335	CbGpPWpGaD
Indapamide—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000806	0.00332	CbGpPWpGaD
Indapamide—CA5A—Metabolism—BCAN—malignant glioma	0.000786	0.00323	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ASMT—malignant glioma	0.000781	0.00321	CbGpPWpGaD
Indapamide—CA7—Metabolism—ASMT—malignant glioma	0.000781	0.00321	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000773	0.00318	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000759	0.00312	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000749	0.00308	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—MDM2—malignant glioma	0.000746	0.00307	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—RAF1—malignant glioma	0.000743	0.00306	CbGpPWpGaD
Indapamide—CA5B—Metabolism—BCAN—malignant glioma	0.000734	0.00302	CbGpPWpGaD
Indapamide—CA7—Metabolism—BCAN—malignant glioma	0.000734	0.00302	CbGpPWpGaD
Indapamide—CA12—Metabolism—ASMT—malignant glioma	0.000723	0.00297	CbGpPWpGaD
Indapamide—CA2—central nervous system—malignant glioma	0.000706	0.0181	CbGeAlD
Indapamide—CA2—cerebellum—malignant glioma	0.00069	0.0177	CbGeAlD
Indapamide—CA9—Cellular responses to stress—SOD1—malignant glioma	0.000686	0.00282	CbGpPWpGaD
Indapamide—CA12—Metabolism—BCAN—malignant glioma	0.00068	0.0028	CbGpPWpGaD
Indapamide—CA4—Metabolism—COX8A—malignant glioma	0.000678	0.00279	CbGpPWpGaD
Indapamide—CA4—brain—malignant glioma	0.000676	0.0173	CbGeAlD
Indapamide—CA9—Cellular responses to stress—GSTP1—malignant glioma	0.00067	0.00276	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000668	0.00275	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000658	0.00271	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CAT—malignant glioma	0.000652	0.00268	CbGpPWpGaD
Indapamide—CA2—Metabolism—COX8A—malignant glioma	0.00065	0.00267	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000649	0.00267	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN2B—malignant glioma	0.000649	0.00267	CbGpPWpGaD
Indapamide—CA5A—Metabolism—IDH2—malignant glioma	0.000634	0.00261	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000615	0.00253	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000614	0.00252	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP2B6—malignant glioma	0.000596	0.00245	CbGpPWpGaD
Indapamide—CA7—Metabolism—IDH2—malignant glioma	0.000592	0.00243	CbGpPWpGaD
Indapamide—CA5B—Metabolism—IDH2—malignant glioma	0.000592	0.00243	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000584	0.0024	CbGpPWpGaD
Indapamide—CA4—Metabolism—ASMT—malignant glioma	0.000577	0.00237	CbGpPWpGaD
Indapamide—CA2—brain—malignant glioma	0.00056	0.0144	CbGeAlD
Indapamide—CA7—Metabolism—CYP2B6—malignant glioma	0.000556	0.00229	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP2B6—malignant glioma	0.000556	0.00229	CbGpPWpGaD
Indapamide—CA2—Metabolism—ASMT—malignant glioma	0.000553	0.00227	CbGpPWpGaD
Indapamide—CA9—Metabolism—COX8A—malignant glioma	0.000548	0.00225	CbGpPWpGaD
Indapamide—CA12—Metabolism—IDH2—malignant glioma	0.000548	0.00225	CbGpPWpGaD
Indapamide—CA5A—Metabolism—IDH1—malignant glioma	0.000545	0.00224	CbGpPWpGaD
Indapamide—CA4—Metabolism—BCAN—malignant glioma	0.000542	0.00223	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000533	0.00219	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000529	0.00218	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SPHK1—malignant glioma	0.000527	0.00217	CbGpPWpGaD
Indapamide—CA2—Metabolism—BCAN—malignant glioma	0.00052	0.00214	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—HIF1A—malignant glioma	0.000519	0.00213	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP2C18—malignant glioma	0.000517	0.00213	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP2B6—malignant glioma	0.000515	0.00212	CbGpPWpGaD
Indapamide—CA7—Metabolism—IDH1—malignant glioma	0.000509	0.00209	CbGpPWpGaD
Indapamide—CA5B—Metabolism—IDH1—malignant glioma	0.000509	0.00209	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SPHK1—malignant glioma	0.000492	0.00202	CbGpPWpGaD
Indapamide—CA7—Metabolism—SPHK1—malignant glioma	0.000492	0.00202	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP2C18—malignant glioma	0.000482	0.00198	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP2C18—malignant glioma	0.000482	0.00198	CbGpPWpGaD
Indapamide—CA12—Metabolism—IDH1—malignant glioma	0.000471	0.00194	CbGpPWpGaD
Indapamide—CA9—Metabolism—ASMT—malignant glioma	0.000466	0.00192	CbGpPWpGaD
Indapamide—CA12—Metabolism—SPHK1—malignant glioma	0.000456	0.00188	CbGpPWpGaD
Indapamide—CYP3A4—central nervous system—malignant glioma	0.000455	0.0117	CbGeAlD
Indapamide—CA12—Metabolism—CYP2C18—malignant glioma	0.000447	0.00184	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000444	0.00183	CbGpPWpGaD
Indapamide—CA9—Metabolism—BCAN—malignant glioma	0.000438	0.0018	CbGpPWpGaD
Indapamide—CA4—Metabolism—IDH2—malignant glioma	0.000437	0.0018	CbGpPWpGaD
Indapamide—CA2—Metabolism—IDH2—malignant glioma	0.000419	0.00172	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTT1—malignant glioma	0.000418	0.00172	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP2B6—malignant glioma	0.000411	0.00169	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000404	0.00166	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP2B6—malignant glioma	0.000394	0.00162	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS1—malignant glioma	0.000391	0.00161	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTT1—malignant glioma	0.00039	0.0016	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTT1—malignant glioma	0.00039	0.0016	CbGpPWpGaD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000383	0.00157	CbGpPWpGaD
Indapamide—CA4—Metabolism—IDH1—malignant glioma	0.000376	0.00155	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN2A—malignant glioma	0.000371	0.00153	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS1—malignant glioma	0.000365	0.0015	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS1—malignant glioma	0.000365	0.0015	CbGpPWpGaD
Indapamide—CA5A—Metabolism—BCHE—malignant glioma	0.000364	0.0015	CbGpPWpGaD
Indapamide—CA4—Metabolism—SPHK1—malignant glioma	0.000364	0.0015	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTT1—malignant glioma	0.000361	0.00149	CbGpPWpGaD
Indapamide—CA2—Metabolism—IDH1—malignant glioma	0.00036	0.00148	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—MDM2—malignant glioma	0.00036	0.00148	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SLC5A5—malignant glioma	0.000359	0.00148	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP2C18—malignant glioma	0.000356	0.00147	CbGpPWpGaD
Indapamide—CA9—Metabolism—IDH2—malignant glioma	0.000353	0.00145	CbGpPWpGaD
Indapamide—CA2—Metabolism—SPHK1—malignant glioma	0.000349	0.00143	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP2C18—malignant glioma	0.000342	0.00141	CbGpPWpGaD
Indapamide—CA7—Metabolism—BCHE—malignant glioma	0.00034	0.0014	CbGpPWpGaD
Indapamide—CA5B—Metabolism—BCHE—malignant glioma	0.00034	0.0014	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS1—malignant glioma	0.000339	0.00139	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CXCL8—malignant glioma	0.000337	0.00138	CbGpPWpGaD
Indapamide—CA7—Metabolism—SLC5A5—malignant glioma	0.000336	0.00138	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SLC5A5—malignant glioma	0.000336	0.00138	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP2B6—malignant glioma	0.000332	0.00137	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000327	0.00134	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000322	0.00133	CbGpPWpGaD
Indapamide—CA12—Metabolism—BCHE—malignant glioma	0.000315	0.00129	CbGpPWpGaD
Indapamide—CA12—Metabolism—SLC5A5—malignant glioma	0.000311	0.00128	CbGpPWpGaD
Indapamide—CA9—Metabolism—IDH1—malignant glioma	0.000304	0.00125	CbGpPWpGaD
Indapamide—CA9—Metabolism—SPHK1—malignant glioma	0.000294	0.00121	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTP1—malignant glioma	0.00029	0.00119	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTT1—malignant glioma	0.000288	0.00119	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP2C18—malignant glioma	0.000288	0.00118	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000283	0.00117	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CAT—malignant glioma	0.000282	0.00116	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000279	0.00115	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTT1—malignant glioma	0.000276	0.00114	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—VEGFA—malignant glioma	0.000273	0.00112	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—STAT3—malignant glioma	0.000271	0.00111	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTP1—malignant glioma	0.00027	0.00111	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTP1—malignant glioma	0.00027	0.00111	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS1—malignant glioma	0.00027	0.00111	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NCOR1—malignant glioma	0.000266	0.00109	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000265	0.00109	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CAT—malignant glioma	0.000263	0.00108	CbGpPWpGaD
Indapamide—CA7—Metabolism—CAT—malignant glioma	0.000263	0.00108	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS1—malignant glioma	0.000259	0.00106	CbGpPWpGaD
Indapamide—CA4—Metabolism—BCHE—malignant glioma	0.000251	0.00103	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTP1—malignant glioma	0.00025	0.00103	CbGpPWpGaD
Indapamide—CA7—Metabolism—NCOR1—malignant glioma	0.000248	0.00102	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NCOR1—malignant glioma	0.000248	0.00102	CbGpPWpGaD
Indapamide—CA4—Metabolism—SLC5A5—malignant glioma	0.000248	0.00102	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000245	0.00101	CbGpPWpGaD
Indapamide—CA12—Metabolism—CAT—malignant glioma	0.000244	0.001	CbGpPWpGaD
Indapamide—CA2—Metabolism—BCHE—malignant glioma	0.000241	0.00099	CbGpPWpGaD
Indapamide—CA2—Metabolism—SLC5A5—malignant glioma	0.000238	0.000978	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTT1—malignant glioma	0.000233	0.000958	CbGpPWpGaD
Indapamide—CA12—Metabolism—NCOR1—malignant glioma	0.00023	0.000947	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000229	0.000943	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS1—malignant glioma	0.000218	0.000898	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CAV1—malignant glioma	0.000217	0.000892	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000215	0.000884	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TP53—malignant glioma	0.000207	0.00085	CbGpPWpGaD
Indapamide—CA9—Metabolism—BCHE—malignant glioma	0.000203	0.000834	CbGpPWpGaD
Indapamide—CA7—Metabolism—CAV1—malignant glioma	0.000203	0.000833	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CAV1—malignant glioma	0.000203	0.000833	CbGpPWpGaD
Indapamide—CA9—Metabolism—SLC5A5—malignant glioma	0.0002	0.000824	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTP1—malignant glioma	0.0002	0.000822	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CG—malignant glioma	0.000198	0.000813	CbGpPWpGaD
Indapamide—CA4—Metabolism—CAT—malignant glioma	0.000194	0.0008	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTP1—malignant glioma	0.000191	0.000788	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PPARG—malignant glioma	0.000191	0.000785	CbGpPWpGaD
Indapamide—CA12—Metabolism—CAV1—malignant glioma	0.000188	0.000772	CbGpPWpGaD
Indapamide—CA2—Metabolism—CAT—malignant glioma	0.000186	0.000767	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CG—malignant glioma	0.000184	0.000759	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CG—malignant glioma	0.000184	0.000759	CbGpPWpGaD
Indapamide—CA4—Metabolism—NCOR1—malignant glioma	0.000184	0.000755	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PPARG—malignant glioma	0.000178	0.000732	CbGpPWpGaD
Indapamide—CA7—Metabolism—PPARG—malignant glioma	0.000178	0.000732	CbGpPWpGaD
Indapamide—CA2—Metabolism—NCOR1—malignant glioma	0.000176	0.000724	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CD—malignant glioma	0.000174	0.000715	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CG—malignant glioma	0.000171	0.000703	CbGpPWpGaD
Indapamide—CA12—Metabolism—PPARG—malignant glioma	0.000165	0.000679	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CD—malignant glioma	0.000162	0.000667	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CD—malignant glioma	0.000162	0.000667	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTP1—malignant glioma	0.000161	0.000664	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000161	0.000661	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000159	0.000654	CbGpPWpGaD
Indapamide—CA9—Metabolism—CAT—malignant glioma	0.000157	0.000646	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000157	0.000645	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CB—malignant glioma	0.000151	0.000623	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CD—malignant glioma	0.00015	0.000618	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—malignant glioma	0.00015	0.000617	CbGpPWpGaD
Indapamide—CA4—Metabolism—CAV1—malignant glioma	0.00015	0.000616	CbGpPWpGaD
Indapamide—CA9—Metabolism—NCOR1—malignant glioma	0.000148	0.00061	CbGpPWpGaD
Indapamide—CA2—Metabolism—CAV1—malignant glioma	0.000143	0.00059	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CB—malignant glioma	0.000141	0.000581	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CB—malignant glioma	0.000141	0.000581	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—malignant glioma	0.00014	0.000576	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—malignant glioma	0.00014	0.000576	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CG—malignant glioma	0.000136	0.000561	CbGpPWpGaD
Indapamide—CA4—Metabolism—PPARG—malignant glioma	0.000132	0.000541	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CB—malignant glioma	0.000131	0.000539	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTEN—malignant glioma	0.000131	0.000538	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CG—malignant glioma	0.000131	0.000538	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—malignant glioma	0.00013	0.000534	CbGpPWpGaD
Indapamide—CA2—Metabolism—PPARG—malignant glioma	0.000126	0.000519	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTEN—malignant glioma	0.000122	0.000502	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTEN—malignant glioma	0.000122	0.000502	CbGpPWpGaD
Indapamide—CA9—Metabolism—CAV1—malignant glioma	0.000121	0.000497	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CD—malignant glioma	0.00012	0.000493	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CD—malignant glioma	0.000115	0.000473	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTEN—malignant glioma	0.000113	0.000465	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CG—malignant glioma	0.00011	0.000453	CbGpPWpGaD
Indapamide—CA9—Metabolism—PPARG—malignant glioma	0.000106	0.000437	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CB—malignant glioma	0.000104	0.00043	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—malignant glioma	0.000103	0.000426	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CB—malignant glioma	0.0001	0.000412	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—malignant glioma	9.92e-05	0.000408	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CD—malignant glioma	9.68e-05	0.000398	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CA—malignant glioma	9.23e-05	0.00038	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—COX8A—malignant glioma	9.23e-05	0.00038	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTEN—malignant glioma	9.02e-05	0.000371	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTEN—malignant glioma	8.65e-05	0.000356	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CA—malignant glioma	8.62e-05	0.000354	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CA—malignant glioma	8.62e-05	0.000354	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CB—malignant glioma	8.44e-05	0.000347	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—malignant glioma	8.36e-05	0.000344	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CA—malignant glioma	7.98e-05	0.000328	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ASMT—malignant glioma	7.84e-05	0.000323	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AKT1—malignant glioma	7.54e-05	0.00031	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—BCAN—malignant glioma	7.38e-05	0.000303	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTEN—malignant glioma	7.29e-05	0.0003	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AKT1—malignant glioma	7.04e-05	0.00029	CbGpPWpGaD
Indapamide—CA7—Metabolism—AKT1—malignant glioma	7.04e-05	0.00029	CbGpPWpGaD
Indapamide—CA12—Metabolism—AKT1—malignant glioma	6.52e-05	0.000268	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CA—malignant glioma	6.37e-05	0.000262	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CA—malignant glioma	6.1e-05	0.000251	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—IDH2—malignant glioma	5.94e-05	0.000245	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP2B6—malignant glioma	5.59e-05	0.00023	CbGpPWpGaD
Indapamide—CA4—Metabolism—AKT1—malignant glioma	5.2e-05	0.000214	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CA—malignant glioma	5.14e-05	0.000212	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—IDH1—malignant glioma	5.11e-05	0.00021	CbGpPWpGaD
Indapamide—CA2—Metabolism—AKT1—malignant glioma	4.99e-05	0.000205	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SPHK1—malignant glioma	4.95e-05	0.000204	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.85e-05	0.000199	CbGpPWpGaD
Indapamide—CA9—Metabolism—AKT1—malignant glioma	4.2e-05	0.000173	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTT1—malignant glioma	3.92e-05	0.000161	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS1—malignant glioma	3.67e-05	0.000151	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—BCHE—malignant glioma	3.41e-05	0.00014	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.37e-05	0.000139	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTP1—malignant glioma	2.72e-05	0.000112	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CAT—malignant glioma	2.64e-05	0.000109	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOR1—malignant glioma	2.5e-05	0.000103	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CAV1—malignant glioma	2.04e-05	8.37e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.85e-05	7.63e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PPARG—malignant glioma	1.79e-05	7.36e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.63e-05	6.7e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.42e-05	5.84e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—malignant glioma	1.41e-05	5.79e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTEN—malignant glioma	1.23e-05	5.05e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CA—malignant glioma	8.66e-06	3.56e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKT1—malignant glioma	7.07e-06	2.91e-05	CbGpPWpGaD
